Article Information
History
- February 19, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Rafail Nikolaos Tasakis1,2,
- Georgios Samaras1,3,
- Anna Jamison4,¶,
- Michelle Lee5,¶,
- Alexandra Paulus4,¶,
- Gabrielle Whitehouse4,¶,
- Laurent Verkoczy6,*,
- F. Nina Papavasiliou1,* and
- Marilyn Diaz6,*
- 1Division of Immune Diversity, German Cancer Research Center (DKFZ), Heidelberg, Germany
- 2Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany
- 3Program of Translational Medical Research, Medical Faculty Mannheim, University of Heidelberg, Germany
- 4The Nightingale-Bamford School, New York, NY, USA
- 5Cornell University, Ithaca, NY, USA
- 6San Diego Biomedical Research Institute (SDBRI), San Diego, CA, USA
- ↵*Co-corresponding authors, Email: mdiaz{at}SDBRI.ORG (MD), Email: lverkoczy{at}SDBRI.ORG (LV), Email: n.papavasiliou{at}dkfz-heidelberg.de (FNP)
↵¶ These authors contributed equally to this work.
Posted February 19, 2021.
SARS-CoV-2 variant evolution in the United States: High accumulation of viral mutations over time likely through serial Founder Events and mutational bursts
